/L). Immature cells were rare on the peripheral blood (PB) smear. The 500-cell differential count from the BM aspirate revealed that 70% of all nucleated cells were blasts with large sizes, high nuclear/cytoplasm (N/C) ratios, irregularly-shape nuclei, dispersed chromatin, distinct nucleoli, and basophilic cytoplasm that occasionally formed pseudopods (Fig. 1A) . Cytochemical staining was negative for myeloperoxidase (MPO), periodic acid-Schiff (PAS), and nonspecific esterase (NSE). The BM biopsy specimen showed hypercellular marrow infiltrated by large immature cells. CD34-specific immunohistochemical staining showed strong positive staining for leukemic blasts.
Flow cytometric analysis of the BM aspirate was performed with a 2-color Beckman Coulter Cytomics FC 500 flow cytometer (Beckman-Coulter, Fullerton, CA, USA). The result revealed that approximately 66% of the large cells were strongly positive for CD19 (99.0% of the gated blasts) and HLA-DR (98.7% of the gated blasts), and negative for all other myeloid (CD13, CD33, CD117, and MPO), B-lymphoid (CD20, CD22, and CD79a), Tlymphoid (CD2, CD3, CD5, CD7, and CD10), and terminal deoxynucleotidyl transferase (TdT) antigens.
On the basis of morphologic features and immunophenotyping results of the BM aspirate, the patient was diagnosed with ALAL according to the 2008 WHO classification [1] . The result of conventional G-banding chromosomal analysis of the bone marrow cells was 89-93,XXYY,+X,-Y,-6,+7,-9,-14,-16,-18,-19,-20[cp6]/ 46,XY [14] (Fig. 1B) . Interphase FISH using a DNA probe set specific for the AML1/ETO, BCR/ABL, MLL, PML/RARA, and CBFB genes (Vysis, Downers Grove, IL, USA) was performed according to the manufacturer's protocols, and the result was nuc ish (RUNX1T1, RUNX1) × 4 [160/200] . Genetic mutation analyses for internal tandem duplication of fms-related tyrosine kinase 3 (FLT3/ITD) and nucleophosmin 1 (NPM1) were performed with bidirectional Sanger sequencing using an ABI PRISM 3730 DNA analyzer (Applied Biosystems, Foster City, CA, USA). The FLT3/ITD results were negative, and the mutation status of NPM1 was wild type.
After the patient received induction chemotherapy, first followup BM examination and cytogenetic analyses were performed. Follow-up BM aspiration showed blasts within the normal range (1.3% of total nucleated cells); however, diffuse infiltration and clusters of immature cells were detected on BM biopsy. Followup cytogenetic analysis showed the presence of near-tetraploidy /L. No immature cells were found on the PB smear. In the BM aspirate, 27.4% of all nucleated cells were large blasts with high N/C ratios, irregularly-shape nuclei, dispersed chromatin, distinct nucleoli, and basophilic cytoplasm (Fig. 1C) . Cytochemical staining was negative for MPO, PAS, and NSE. The BM biopsy specimen showed normocellular marrow infiltrated by large immature cells. CD34-specific immunohistochemical analysis showed strong positive staining for leukemic blasts. The result of flow cytometric analysis of the BM aspirate revealed that approximately 21% of the large cells were strongly positive for CD13 (60.2% of the gated blasts), cCD79a (39.5% of the gated blasts), CD61 (25.9% of the gated blasts), TdT (56.6% of the gated blasts), and HLA-DR (62.7% of the gated blasts), and negative for all other myeloid, B-lymphoid, and T-lymphoid antigens.
On the basis of the morphologic features and immunophenotyping results of the BM aspirate, the patient was diagnosed with ALAL according to the 2008 WHO classification [1] . The result of conventional G-banding chromosomal analysis was 93,XXYY,+13 [8] Here, we report 2 cases of rare ALAL with near-tetraploidy. Immunophenotyping of the first patient showed strong positivity only for CD19 and negativity for CD79a, cCD22, and CD10. Therefore, we could not assign a B-lineage. Overall, no clear evidence of differentiation along a single lineage was found, but due to strong positivity for CD19, we could not diagnose acute undifferentiated leukemia. Finally, we were able to diagnose the first case as ALAL. In the second case, since the patient's immunophenotype showed no activity for MPO, monocytic markers, CD3, or CD19, we also could not assign any specific lineage. Although cCD79a staining was positive, the staining intensity was dim and there was no positivity for other B-cell lineage markers; hence, we excluded the possibility of B-cell ALL. CD61 staining also showed weak positivity, but the morphologic characteristics of the blasts were not similar to those of megakaryoblasts. In addition, it is well known that false-positive flow cytometric detection of platelet glycoprotein expression in myeloid leukemia secondary to platelet adherence to leukemic blasts occurs frequently (up to 85% of AML cases) [5] . The patient's flow cytometry dot plot for CD45 and side scatter (SSC) showed a diffuse platelet adhesion pattern in other cell populations, and therefore, he could not be diagnosed with acute megakaryoblastic leukemia. The WHO suggests that the lack of an assignable lineage in combination with the expression of no more than 1 nondefinitive antigen for any given lineage could be called acute undifferentiated leukemia, while similar neoplasms with more than 1 suggestive antigen in each of more than 1 lineage should be considered acute unclassifiable leukemia [6] . By definition, acute undifferentiated leukemia lacks the T or myeloid lineagespecific markers and does not express B-cell specific markers [1] . In case 2, the immunophenotype showed positivity for 1 myeloid nondefinitive antigen (CD33), but also for 1 B-cell lineage specific antigen (cCD79a); therefore, a diagnosis of acute undifferentiated leukemia and acute unclassifiable leukemia could not be made. There was no evidence of nonhematopoietic neoplasm, NK-cell leukemia, or other myeloid leukemia such as acute erythroid leukemia. For these reasons, the second patient was diagnosed with ALAL.
CD34 immunohistochemical staining showed strong positivity in both our patients, and this is similar to findings from other reports [7] . This finding revealed that the blasts of the 2 patients in this study had immature characteristics.
Previous study showed that increased DNA content is directly related to blast size [8] . In the 2 cases presented here, the blasts were large in size with high N/C ratios, irregular nuclear configuration, and distinct multiple nucleoli, which were consistent with those by Zhang et al. [8] . These results indicate that if giant and bizarre blasts are found in BM aspirate smears from patients with leukemia, tetraploid or near-tetraploid karyotypes should also be considered.
In general, tumors with tetraploidy have a high degree of malignancy and patient survival is relatively short [8] . Some authors have suggested that the great variety of chromosome numbers suggests a global defect in cell cycle control, leading to poor responses to chemotherapy [9] . The first patient did not achieve complete remission and had short survival duration of 82 days. We believe that abnormal tetraploid karyotypes may contribute to the observed laboratory and clinical features and lead to poor responses to therapy and poor prognoses.
In the second case, the patient refused chemotherapy for ALAL. If we assume that this patient survived for 6 patient's outcome was better than that of the first. The following reasons may explain the difference in prognosis. First, the ages of the 2 patients differed. Human cell proliferation slows with increasing age. Thus, the more advanced age of the second patient may have led to slower disease progression. Second, the marrow blast count of the second patient was lower than that of the first patient. Third, according to the literature, tetraploidy or near-tetraploidy together with additional cytogenetic changes could be considered a prognostic marker of resistance to chemotherapy and poor outcomes [10] . The first patient in our study had more chromosome aberrations than the second patient, which may have contributed to the difference in outcomes. In addition, some studies have shown that loss of chromosomal material is associated with poor prognosis in cancer patients [11] . The first case showed more chromosomal loss than the second case; hence, we suggest that loss of chromosome material may have been associated with his poorer prognosis. Further studies, such as a comparative genomic hybridization study with more cases of near-tetraploidy, will be needed to confirm these hypotheses.
FLT3/ITD and NPM1 mutations are associated with outcomes of AML [1] . FLT3 analysis in patients with AML with near-tetraploidy has been recommended to better understand the role of this mutation [12] . On the basis of these considerations, we analyzed FLT3/ITD and NPM1 mutation status in our cases, but the results were all negative. Further studies will be needed to evaluate the relationship between gene mutations and near-tetraploidy.
To our knowledge, these are the first reported cases of neartetraploidy in patients with ALAL in Korea. Cases of acute leukemias with tetraploid karyotypes are rare. Consequently, the number of studies on the laboratory and clinical features of these patients are also limited. Further studies, such as DNA content determination, will provide more convincing evidence to make a tentative diagnosis of leukemia based on morphologic observations. The findings of these case reports will be helpful for evaluating tetraploidy or near-tetraploidy associated with ALAL.
